ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Atlanta, GA, USA:

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Atlanta, Georgia, United States and 8 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...

Enrolling
Prostate Cancer
Drug: ARX517

Phase 1

Ambrx

Atlanta, Georgia, United States and 8 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Atlanta, Georgia, United States and 48 other locations

To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

Active, not recruiting
Neuroendocrine Prostate Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Atlanta, Georgia, United States and 20 other locations

ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-specific antige...

Active, not recruiting
Adenocarcinoma of the Prostate
Prostate Cancer
Drug: BMS-986253
Drug: Nivolumab

Phase 1, Phase 2

Mark Stein

Atlanta, Georgia, United States and 3 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Atlanta, Georgia, United States and 29 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Atlanta, Georgia, United States and 111 other locations

injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy....

Not yet enrolling
MRI Scan
Drug: MT218 injection

Phase 1, Phase 2

Molecular Theranostics LLC

Atlanta, Georgia, United States

Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiog...

Enrolling
Prostate Cancer Metastatic
Neuroendocrine Tumors
Drug: Pembrolizumab
Drug: Lenvatinib

Phase 2

University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center

Atlanta, Georgia, United States and 4 other locations

This is a phase I, clinical research study of EPI-7386, an investigational drug being studied as a treatment for patients with prostate cancer...

Enrolling
Prostate Cancer
Drug: EPI-7386 (QD)
Drug: EPI-7386 (BID)

Phase 1

ESSA Pharma

Atlanta, Georgia, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems